STRs in panel
Prev Next
Regions in panel
Prev Next

Hyperparathyroidism

Gene: CDKN1B

Green List (high evidence)

CDKN1B (cyclin dependent kinase inhibitor 1B)
EnsemblGeneIds (GRCh38): ENSG00000111276
EnsemblGeneIds (GRCh37): ENSG00000111276
OMIM: 600778, ClinGen, DECIPHER
CDKN1B is in 10 panels

1 review

Ain Roesley (Victorian Clinical Genetics Services)

Green List (high evidence)

>3 families reported
Created: 19 Apr 2022, 10:08 a.m. | Last Modified: 19 Apr 2022, 10:08 a.m.
Panel Version: 0.13033

Phenotypes
Multiple endocrine neoplasia type 4, MEN4, OMIM #610755

Publications

Variants in this GENE are reported as part of current diagnostic practice

Details

Mode of Inheritance
MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
Sources
  • Expert Review Green
  • Victorian Clinical Genetics Services
Phenotypes
  • Multiple endocrine neoplasia type 4, MEN4, OMIM #610755
OMIM
600778
ClinGen
CDKN1B
DECIPHER
CDKN1B
Clinvar variants
Variants in CDKN1B
Penetrance
None
Publications
Panels with this gene

History Filter Activity

29 Jan 2026, Gel status: 3

Entity classified by Genomics England curator

Chirag Patel (Genetic Health Queensland)

Gene: cdkn1b has been classified as Green List (High Evidence).

29 Jan 2026, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes

Chirag Patel (Genetic Health Queensland)

gene: CDKN1B was added gene: CDKN1B was added to Hyperparathyroidism. Sources: Expert Review Green,Victorian Clinical Genetics Services Mode of inheritance for gene: CDKN1B was set to MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted Publications for gene: CDKN1B were set to 24819502; 17030811; 23555276 Phenotypes for gene: CDKN1B were set to Multiple endocrine neoplasia type 4, MEN4, OMIM #610755